Pharmaceutical manufacturer recalls 11 eye medicines amid quality concerns

A pharmaceutical manufacturer has voluntarily recalled 11 ophthalmic products and temporarily halted their production following quality concerns at its Assam manufacturing facility. The action follows reported regulatory findings of deficiencies in quality management systems, with the company undertaking corrective measures before resuming manufacturing and supplies.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.